Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (411-420 of 621) with videos related to

Pageof 63
Sort By:
Nature Communications|March 15, 2012
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisAlfiya Akhmetshina, Katrin Palumbo, Clara Dees, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)|January 24, 2018
Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseasesMaurizio Cutolo, Karin Melsens, Ariane L Herrick, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Genome Biology|August 26, 2021
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritabilityXiangyu Ge, Mojca Frank-Bertoncelj, Kerstin Klein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2019
Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic SclerosisAlina Soare, Hermina A Györfi, Alexandru E Matei, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
Pageof 63

Showing results (411-420 of 621) with videos related to

Sort By:
Pageof 63
Nature Communications|March 15, 2012
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisAlfiya Akhmetshina, Katrin Palumbo, Clara Dees, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 8, 2019
Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery PressureChristian Nagel, Alberto M Marra, Nicola Benjamin, et al.
Rheumatology (Oxford, England)|January 24, 2018
Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseasesMaurizio Cutolo, Karin Melsens, Ariane L Herrick, et al.
Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.
Genome Biology|August 26, 2021
Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritabilityXiangyu Ge, Mojca Frank-Bertoncelj, Kerstin Klein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2019
Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic SclerosisAlina Soare, Hermina A Györfi, Alexandru E Matei, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyJ Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
Pageof 63